USA • New York Stock Exchange • NYSE:ABT • US0028241000
We assign a fundamental rating of 6 out of 10 to ABT. ABT was compared to 184 industry peers in the Health Care Equipment & Supplies industry. ABT scores excellent on profitability, but there are some minor concerns on its financial health. ABT has a decent growth rate and is not valued too expensively. Finally ABT also has an excellent dividend rating. These ratings would make ABT suitable for dividend investing!
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROIC | 8.88% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Altman-Z | 5.13 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.22 | ||
| Fwd PE | 19.06 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.48 | ||
| EV/EBITDA | 16.99 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.38% |
ChartMill assigns a fundamental rating of 6 / 10 to ABT.
ChartMill assigns a valuation rating of 6 / 10 to ABBOTT LABORATORIES (ABT). This can be considered as Fairly Valued.
ABBOTT LABORATORIES (ABT) has a profitability rating of 7 / 10.
The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABT) is 21.22 and the Price/Book (PB) ratio is 3.73.
The Earnings per Share (EPS) of ABBOTT LABORATORIES (ABT) is expected to grow by 11.35% in the next year.